Trade Summary

1 week ago, Montalbano John S., serving as Dir at Abcellera Biologics Inc. (ABCL), purchased 20,000 shares at $4.77 per share, for a total transaction value of $95,400.00. Following this transaction, Montalbano John S. now holds 246,000 shares of ABCL.

This purchase represents a 9.00% increase in Montalbano John S.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 14, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 18, 2026 at 12:09 PM ET, 4 days after the trade was made.

Abcellera Biologics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.